Doktor axborotnomasi 2023, №4 (112)

Maqola mavzusi

SURGICAL REMOVAL OF HEPATOCELLULAR CARCINOMA (96-99)

Mualliflar

F. G. Ulmasov, A. A. Kuliyev, B. S. Esankulova, A. Y. Turayev

Muassasa

Samarkand state medical university, Samarkand, Uzbekistan

Annotatsiya

Hepatocellular carcinoma (HCC) is a primary malignancy of the liver associated with significant morbidity and mortality. Surgical resection remains a cornerstone in the management of localized disease, offering a curative option for eligible patients. This case report highlights the successful surgical resection of an entire HCC tumor.

Kalit so'zlar

hepatocellular carcinoma, resection, liver.

Adabiyotlar

1. Aloia TA. Associating liver partition and portal vein ligation for staged hepatectomy: portal vein embolization should remain the gold standard. JAMA Surg. (2015) 150:927–8. doi: 10.1001/jamasurg.2015.1646 2. Charalel RA, Sung J, Askin G, Jo J, Mitry M, Chung C, et al. Systematic reviews and meta-analyses of portal vein embolization, associated liver partition and portal vein ligation, and radiation lobectomy outcomes in hepatocellu-lar carcinoma patients. Curr Oncol Rep. (2021) 23:135. doi: 10.1007/s11912-021-01075-1 3. Piron L, Deshayes E, Escal L, Souche R, Herrero A, Pierredon-Foulongne MA, et al. [Portal vein embolization: present and future]. Bull Cancer. (2017) 104:407–16. doi: 10.1016/j.bulcan.2017.03.009 4. He MK, Le Y, Li QJ, Yu ZS, Li SH, Wei W, et al. Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study. Chin J Cancer. (2017) 36:83. doi: 10.1186/s40880-017-0251-2 5. Park JW, Chen M, Colombo M, Roberts LR, Schwartz M, Chen PJ, et al. Global patterns of hepatocellular carci-noma management from diagnosis to death: the BRIDGE study. Liver Int. (2015) 35:2155–66. doi: 10.1111/liv.12818 6. Chan A, Zhang WY, Chok K, Dai J, Ji R, Kwan C, et al. ALPPS versus portal vein embolization for hepatitis-related hepatocellular carcinoma: a changing paradigm in modulation of future liver remnant before major hepa-tectomy. Ann Surg. (2021) 273:957–65. doi: 10.1097/SLA.0000000000003433 7. Shapiro, V.E., Karev, V.E. Gepatocellyulyarnaya karcinoma, associirovannaya s virusom gepatita V. – M., 2007. – 143 s. 8. Shahgil’dyan, I.V. Parenteral’nye virusnye gepatity (ehpidemiologiya, diagnostika, profilaktika) / I.V. Shah-gil’dyan, M.I. Mihajlov, G.G. Onishchenko. – M.: VUNMC Minzdrava RF, 2003. – 384 s. 9. Yushchuk, N.D. Protokol diagnostiki i lecheniya bol’nyh virusnymi gepatitami V i S / N.D. Yushchuk, E.A. Klimova, O.O. Znojko i dr. // Ros. zhurn. gastroehnterol., gepatolog., koloproktol. – 2010. – T. 20. – № 6. – S. 4-60. 10. Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality / Y. Tanaka, F. Kurbanov, S. Mano et al. // Gastroenterology. – 2006. – N130. – P. 703-714. 11. Chronic viral hepatitis and hepatocellular carcinoma / Y. Barazani, J.R. Hiatt, M.J. Tong [et al.] // World J. Surg. – 2007. – Vol. 31. – P. 1245-1250. 14. Role of hepatitis delta virus infection in hepatocellular carcinoma /G. Verme, M.R. Brunetto, F. Oliveri et al. // Dig. Dis. Sci. – 1991. – Vol.36. – P. 1134-1136. 12. Zhang J, Zhang X, Mu H, Yu G, Xing W, Wang L, et al. Surgical conversion for initially unresectable locally ad-vanced hepatocellular carcinoma using a triple combination of angiogenesis inhibitors, anti-PD-1 antibodies, and hepatic arterial infusion chemotherapy: a retrospective study. Front Oncol. (2021) 11:729764. doi: 10.3389/fonc.2021.729764 13. Mei J, Tang YH, Wei W, Shi M, Zheng L, Li SH, et al. Hepatic arterial infusion chemotherapy combined with PD-1 inhibitors plus lenvatinib versus PD-1 inhibitors plus lenvatinib for advanced hepatocellular carcinoma. Front Oncol. (2021) 11:618206. doi: 10.3389/fonc.2021.618206 14. Zhdanov, K.V. Latentnye formy virusnyh gepatitov V i S u lic molodogo vozrasta: avtoref. dis. … d-ra med. nauk / V.M. Zhdanov. – SPb., 2000. – 45 s. 15. Krenchyk, D. Rol’ del’ta-infekcii v razvitii hronicheskih gepatitov: avtoref. dis. … kand. med. nauk / D. Krenchyk. – M., 1990. – 24 s.